5 October 2026 Punjab Khabarnama Bureau : A new study has found that people who have had COVID-19 may face an increased risk of developing several allergic conditions, adding to growing evidence that the infection can have effects on the immune system that extend beyond the initial illness.
Researchers examined the relationship between previous COVID-19 infection and the later development of allergic diseases. Their findings suggest that people who recovered from COVID-19 had a higher likelihood of being diagnosed with six different allergic conditions compared with people who had not been infected.
The study adds to a growing body of research investigating the long-term health consequences of SARS-CoV-2 infection. While COVID-19 is primarily known as a respiratory infection, scientists have increasingly been examining its potential effects on multiple organs and biological systems, including the immune system.
Allergic diseases occur when the immune system reacts excessively to substances that are normally harmless. Depending on the condition, symptoms can affect the skin, respiratory system or other parts of the body. Common allergic disorders include asthma, allergic rhinitis, eczema and certain food or environmental allergies.
The researchers found an association between COVID-19 infection and an increased risk of several allergic conditions. However, the findings do not necessarily establish that COVID-19 directly causes these diseases. An observed association can be influenced by other factors, including underlying health conditions, environmental exposure, healthcare-seeking behaviour and changes in immune function.
The immune system plays a central role in both fighting infections and regulating allergic reactions. Researchers have proposed that COVID-19 may temporarily or persistently alter immune responses in some individuals. Such changes could potentially influence inflammatory pathways involved in allergic diseases.
The findings are therefore significant because they provide another area for researchers to investigate as they continue studying the consequences of COVID-19.
COVID-19 has previously been associated with a wide range of post-infection symptoms and health problems. Some people experience persistent fatigue, breathing difficulties, neurological symptoms or other complications after the acute infection has resolved. The condition commonly referred to as long COVID remains an active area of scientific research.
The latest findings do not mean that everyone who has had COVID-19 will develop an allergic disease. Most people who recover from the infection will not necessarily experience such complications, and individual risk can vary depending on age, health status, severity of infection and other factors.
The study’s findings may nevertheless be relevant to doctors monitoring patients who develop new or worsening allergy-like symptoms after recovering from COVID-19. Symptoms such as persistent nasal congestion, sneezing, wheezing, skin irritation or unexplained allergic reactions may require medical evaluation to determine their underlying cause.
Researchers emphasize that further studies will be needed to understand the biological mechanisms behind the observed association. Large-scale studies involving diverse populations could help establish whether the relationship remains consistent across different age groups, ethnic backgrounds and levels of COVID-19 severity.
Scientists also need to determine whether the risk varies according to the severity of the infection. People who experienced mild COVID-19 may have different long-term immune responses compared with those who required hospitalization or intensive care.
Vaccination status may also be an important factor in future research. COVID-19 vaccines can reduce the risk of severe disease, and researchers continue to examine how vaccination and prior infection together influence long-term health outcomes.
Another important consideration is the changing nature of the virus. SARS-CoV-2 has evolved considerably since the beginning of the pandemic, with successive variants differing in transmissibility and disease severity. Whether the potential relationship between infection and allergic disease remains similar across variants is an area that warrants further investigation.
The study also highlights the complexity of the human immune system. An immune response that is beneficial during an infection can sometimes be followed by prolonged inflammation or changes in immune regulation. Understanding these processes could help researchers identify people who are more vulnerable to post-infectious conditions.
For the public, the findings should be interpreted carefully. The research indicates an association rather than proof that COVID-19 directly causes six allergic diseases. It does not mean that individuals who have recovered from COVID-19 should expect to develop allergies.
People experiencing new symptoms after COVID-19 should discuss them with a healthcare professional rather than assuming that the symptoms are automatically related to the infection. Allergic symptoms can have many causes, including seasonal allergens, pollution, dust, food, medications and other environmental triggers.
The findings nevertheless add to the scientific understanding of COVID-19 and its potential long-term effects. As researchers continue to follow people who have experienced infection, a clearer picture is emerging of how the virus may interact with the immune system after the initial illness.
Further research will be important to determine whether the increased risk identified in the study persists over time, which patients are most vulnerable and whether specific interventions can reduce the likelihood of developing allergic conditions following infection.
For now, the research provides another reason for scientists to continue studying COVID-19 beyond its acute respiratory effects. The possible connection between previous infection and allergic disease underscores the importance of monitoring long-term health outcomes and understanding the broader consequences of viral infections.